Charles River Laboratories International, Inc. (CRL) Earnings
NYSE·Healthcare·Medical - Diagnostics & Research
$165.80
-3.17%
Mkt Cap $9.12B
Next Earnings
In 8 daysThu, May 7, 2026
EPS Estimate
$1.96
8 analysts
Revenue Estimate
$977.46M
Last quarter: beat by +2.58% on EPS, +0.73% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$9.12B
P/E
—
Fwd P/E
15.44
P/S
2.27
Rev TTM
—
EPS TTM
-$2.96